Nutriband (NASDAQ:NTRBW) Stock Price Down 26.6% – Time to Sell?

Shares of Nutriband Inc. (NASDAQ:NTRBW) traded down 26.6% during mid-day trading on Friday . The company traded as low as $1.12 and last traded at $1.12. 99 shares changed hands during trading, a decline of 95% from the average session volume of 2,067 shares. The stock had previously closed at $1.5250.

Nutriband Stock Performance

The business has a 50 day simple moving average of $1.30 and a 200-day simple moving average of $1.48.

Hedge Funds Weigh In On Nutriband

An institutional investor recently bought a new position in Nutriband stock. Empery Asset Management LP purchased a new stake in shares of Nutriband Inc. (NASDAQ:NTRBW) in the fourth quarter, according to the company in its most recent filing with the SEC. The fund purchased 40,218 shares of the company’s stock, valued at approximately $65,000. Nutriband comprises 0.1% of Empery Asset Management LP’s investment portfolio, making the stock its 20th largest position.

Nutriband Company Profile

Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility.